• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类常染色体隐性疾病的患病率、遗传复杂性及特定人群的奠基者效应

The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders.

作者信息

Xiao Qingyang, Lauschke Volker M

机构信息

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

出版信息

NPJ Genom Med. 2021 Jun 2;6(1):41. doi: 10.1038/s41525-021-00203-x.

DOI:10.1038/s41525-021-00203-x
PMID:34078906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8172936/
Abstract

Autosomal recessive (AR) disorders pose a significant burden for public health. However, despite their clinical importance, epidemiology and molecular genetics of many AR diseases remain poorly characterized. Here, we analyzed the genetic variability of 508 genes associated with AR disorders based on sequencing data from 141,456 individuals across seven ethnogeographic groups by integrating variants with documented pathogenicity from ClinVar, with stringent functionality predictions for variants with unknown pathogenicity. We first validated our model using 85 diseases for which population-specific prevalence data were available and found that our estimates strongly correlated with the respective clinically observed disease frequencies (r = 0.68; p < 0.0001). We found striking differences in population-specific disease prevalence with 101 AR diseases (27%) being limited to specific populations, while an additional 305 diseases (68%) differed more than tenfold across major ethnogeographic groups. Furthermore, by analyzing genetic AR disease complexity, we confirm founder effects for cystic fibrosis and Stargardt disease, and provide strong evidences for >25 additional population-specific founder mutations. The presented analyses reveal the molecular genetics of AR diseases with unprecedented resolution and provide insights into epidemiology, complexity, and population-specific founder effects. These data can serve as a powerful resource for clinical geneticists to inform population-adjusted genetic screening programs, particularly in otherwise understudied ethnogeographic groups.

摘要

常染色体隐性(AR)疾病给公共卫生带来了沉重负担。然而,尽管它们具有临床重要性,但许多AR疾病的流行病学和分子遗传学特征仍不清楚。在此,我们通过整合来自ClinVar的具有已记录致病性的变异,并对致病性未知的变异进行严格的功能预测,基于来自七个种族地理群体的141,456人的测序数据,分析了与AR疾病相关的508个基因的遗传变异性。我们首先使用85种有特定人群患病率数据的疾病验证了我们的模型,发现我们的估计值与各自临床观察到的疾病频率高度相关(r = 0.68;p < 0.0001)。我们发现特定人群疾病患病率存在显著差异,101种AR疾病(27%)仅限于特定人群,而另外305种疾病(68%)在主要种族地理群体中的差异超过十倍。此外,通过分析遗传性AR疾病的复杂性,我们证实了囊性纤维化和斯塔加特病的奠基者效应,并为另外25种以上特定人群的奠基者突变提供了有力证据。所呈现的分析以前所未有的分辨率揭示了AR疾病的分子遗传学,并提供了对流行病学、复杂性和特定人群奠基者效应的见解。这些数据可作为临床遗传学家的有力资源,为人群调整后的基因筛查项目提供信息,特别是在其他研究较少的种族地理群体中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/8ed48728a037/41525_2021_203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/06f60844a816/41525_2021_203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/587deb961a14/41525_2021_203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/8ed48728a037/41525_2021_203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/06f60844a816/41525_2021_203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/587deb961a14/41525_2021_203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698e/8172936/8ed48728a037/41525_2021_203_Fig3_HTML.jpg

相似文献

1
The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders.人类常染色体隐性疾病的患病率、遗传复杂性及特定人群的奠基者效应
NPJ Genom Med. 2021 Jun 2;6(1):41. doi: 10.1038/s41525-021-00203-x.
2
Ethnogeographic and inter-individual variability of human ABC transporters.人类 ABC 转运蛋白的种族地理和个体间变异性。
Hum Genet. 2020 May;139(5):623-646. doi: 10.1007/s00439-020-02150-6. Epub 2020 Mar 23.
3
The genetic landscape of the human solute carrier (SLC) transporter superfamily.人类溶质载体(SLC)转运蛋白超家族的遗传景观。
Hum Genet. 2019 Dec;138(11-12):1359-1377. doi: 10.1007/s00439-019-02081-x. Epub 2019 Nov 2.
4
Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data.基于人群遗传数据的单基因常染色体隐性疾病的患病率估计。
Hum Genet. 2015 Jun;134(6):659-69. doi: 10.1007/s00439-015-1551-8. Epub 2015 Apr 19.
5
Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases.全球常染色体隐性遗传性视网膜疾病的携带者频率和遗传流行率。
Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2710-2716. doi: 10.1073/pnas.1913179117. Epub 2020 Jan 21.
6
Genetic disease risks of under-represented founder populations in New York City.纽约市代表性不足的奠基人群体的遗传疾病风险。
medRxiv. 2024 Sep 28:2024.09.27.24314513. doi: 10.1101/2024.09.27.24314513.
7
Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.高度近亲通婚人群原发性免疫缺陷病基因研究的经验教训
Front Immunol. 2017 Jun 27;8:737. doi: 10.3389/fimmu.2017.00737. eCollection 2017.
8
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.
9
Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.从遗传数据库计算常染色体隐性遗传线粒体疾病的终生风险。
EBioMedicine. 2020 Apr;54:102730. doi: 10.1016/j.ebiom.2020.102730. Epub 2020 Apr 16.
10
Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutations.非综合征性视网膜色素变性在耶路撒冷地区高度流行,存在高频的奠基者突变。
Mol Vis. 2015 Jul 17;21:783-92. eCollection 2015.

引用本文的文献

1
Regional patterns of genetic variants in expanded carrier screening: a next-generation sequencing pilot study in Fujian Province, China.扩展携带者筛查中基因变异的区域模式:中国福建省的一项二代测序试点研究
Front Genet. 2025 May 12;16:1527228. doi: 10.3389/fgene.2025.1527228. eCollection 2025.
2
5'UTR gene regions in germline DNA sequencing panels: lessons from the analysis of breast and ovarian cancer patients of Tatar and Bashkir ethnic origin.种系DNA测序面板中的5'UTR基因区域:来自对鞑靼族和巴什基尔族乳腺癌和卵巢癌患者分析的经验教训
Fam Cancer. 2025 May 26;24(2):50. doi: 10.1007/s10689-025-00477-5.
3
Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases.

本文引用的文献

1
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
2
Documentation of clinically relevant genomic biomarker allele frequencies in the next-generation FINDbase worldwide database.在下一代 FINDbase 全球数据库中记录与临床相关的基因组生物标志物等位基因频率。
Hum Mutat. 2020 Jun;41(6):1112-1122. doi: 10.1002/humu.24018. Epub 2020 Apr 14.
3
Ethnogeographic and inter-individual variability of human ABC transporters.
非靶向蛋白质组学能够在线粒体疾病和其他罕见病中实现超快速的变异体优先级排序。
Genome Med. 2025 May 22;17(1):58. doi: 10.1186/s13073-025-01467-z.
4
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase.利用实验室进化的CRISPR相关转座酶在人类细胞中进行可编程基因插入。
Science. 2025 May 15;388(6748):eadt5199. doi: 10.1126/science.adt5199.
5
Carrier Frequency of Autosomal Recessive Diseases in a Population Attending a Human Fertility Institute in Colombia.哥伦比亚一家人类生育研究所就诊人群中常染色体隐性疾病的携带频率
JBRA Assist Reprod. 2025 Mar 13;29(2):258-71. doi: 10.5935/1518-0557.20240102.
6
CFAP47 is Implicated in X-Linked Polycystic Kidney Disease.CFAP47与X连锁多囊肾病有关。
Kidney Int Rep. 2024 Sep 24;9(12):3580-3591. doi: 10.1016/j.ekir.2024.09.013. eCollection 2024 Dec.
7
Rapid Sex Chromosome Turnover in African Clawed Frogs (Xenopus) and the Origins of New Sex Chromosomes.非洲爪蟾(非洲爪蟾属)的性染色体快速更替与新性染色体的起源
Mol Biol Evol. 2024 Dec 5;41(12). doi: 10.1093/molbev/msae234.
8
An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.PLA2G6 相关神经退行性疾病的全球遗传患病率估计。
Orphanet J Rare Dis. 2024 Oct 18;19(1):388. doi: 10.1186/s13023-024-03275-x.
9
Genetics, Pathophysiology, and Current Challenges in Von Hippel-Lindau Disease Therapeutics.冯·希佩尔-林道病治疗中的遗传学、病理生理学及当前挑战
Diagnostics (Basel). 2024 Aug 29;14(17):1909. doi: 10.3390/diagnostics14171909.
10
Founder mutations and rare disease in the Arab world.阿拉伯世界的创始突变和罕见病。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050715. Epub 2024 Jun 26.
人类 ABC 转运蛋白的种族地理和个体间变异性。
Hum Genet. 2020 May;139(5):623-646. doi: 10.1007/s00439-020-02150-6. Epub 2020 Mar 23.
4
Determining the incidence of rare diseases.确定罕见病的发病率。
Hum Genet. 2020 May;139(5):569-574. doi: 10.1007/s00439-020-02135-5. Epub 2020 Feb 13.
5
Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases.全球常染色体隐性遗传性视网膜疾病的携带者频率和遗传流行率。
Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2710-2716. doi: 10.1073/pnas.1913179117. Epub 2020 Jan 21.
6
The genetic landscape of the human solute carrier (SLC) transporter superfamily.人类溶质载体(SLC)转运蛋白超家族的遗传景观。
Hum Genet. 2019 Dec;138(11-12):1359-1377. doi: 10.1007/s00439-019-02081-x. Epub 2019 Nov 2.
7
Quantifying the contribution of recessive coding variation to developmental disorders.量化隐性编码变异对发育障碍的贡献。
Science. 2018 Dec 7;362(6419):1161-1164. doi: 10.1126/science.aar6731. Epub 2018 Nov 8.
8
Performance evaluation of pathogenicity-computation methods for missense variants.错义变异致病性计算方法的性能评估。
Nucleic Acids Res. 2018 Sep 6;46(15):7793-7804. doi: 10.1093/nar/gky678.
9
Identification of Misclassified ClinVar Variants via Disease Population Prevalence.通过疾病人群患病率识别错误分类的 ClinVar 变异体。
Am J Hum Genet. 2018 Apr 5;102(4):609-619. doi: 10.1016/j.ajhg.2018.02.019.
10
Haemochromatosis.血色病。
Nat Rev Dis Primers. 2018 Apr 5;4:18016. doi: 10.1038/nrdp.2018.16.